A closer look at the making of a novel stem cell therapy for Parkinson’s Disease
A recent publication by MultiPark researchers at Lund University’s Lund Stem Cell Center gives a closer look at the making of a novel stem cell therapy for Parkinson’s Disease, STEM-PD, which has been approved for a Phase I/IIa clinical trial in Europe. Parkinson's Disease is a neurodegenerative disorder that affects almost 8 million people worldwide, causing movement difficulties due to the loss
https://www.multipark.lu.se/article/closer-look-making-novel-stem-cell-therapy-parkinsons-disease - 2025-10-07